Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
AI Drug Discovery Pioneer, Nanyang Biologics Pte. Ltd., Enters into Business Combination Agreement with RF Acquisition Corp II in US$1.5B Transaction to Pursue Public Listing 2025-10-02 19:50
1